financetom
Business
financetom
/
Business
/
D.R. Horton Tops Fiscal Third-Quarter Views, Narrows Full-Year Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
D.R. Horton Tops Fiscal Third-Quarter Views, Narrows Full-Year Revenue Guidance
Jul 18, 2024 10:05 AM

12:56 PM EDT, 07/18/2024 (MT Newswires) -- Shares of D.R. Horton ( DHI ) soared intraday Thursday after the homebuilder's fiscal third-quarter results unexpectedly advanced year over year while the company narrowed its revenue forecast for the full year.

Revenue increased to $9.97 billion for the three months ended June 30 from $9.73 billion the year earlier and surpassed the $9.61 billion average analyst estimate on Capital IQ. Earnings per share climbed to $4.10 from $3.90 year over year and beat the $3.79 GAAP consensus.

Homebuilding revenue increased 6% to $9.24 billion while homes closed rose 5% to 24,155 units. Orders edged up 1% to 23,001 homes and were flat in value at $8.7 billion. Shares of DR Horton ( DHI ) were up 11% in midday trade.

"Although inflation and mortgage interest rates remain elevated, the supply of both new and existing homes at affordable price points is still limited, and demographics supporting housing demand continue to be favorable," Executive Chairman David Auld said in a statement.

Revenue from D.R. Horton's ( DHI ) rental operations was $413.7 million, compared with $667.1 million in 2023's third quarter. Financial services revenue rose to $242.3 million from $228.5 million.

Revenue at Forestar ( FOR ) , a residential lot development company that's majority owned by D.R. Horton ( DHI ), dipped to $318.4 million from $368.9 million in the year-ago period.

Pointing to current market conditions and year-to-date results, the company narrowed its consolidated revenue guidance to a range of $36.8 billion to $37.2 billion for fiscal 2024, compared with its prior forecast between $36.7 billion and $37.7 billion. The market view is for revenue of $36.9 billion in the ongoing year.

The company is now projecting homes closed in its homebuilding operation will reach between 90,000 and 90,500 homes this year, compared with its previous expectation of 89,000 to 91,000 homes.

Price: 174.11, Change: +16.60, Percent Change: +10.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alliance Laundry Q3 Adjusted Earnings, Revenue Rise
Alliance Laundry Q3 Adjusted Earnings, Revenue Rise
Nov 13, 2025
07:11 AM EST, 11/13/2025 (MT Newswires) -- Alliance Laundry ( ALH ) reported Q3 adjusted earnings Thursday of $0.28 per share, up from $0.19 a year earlier. An analyst surveyed by FactSet expected $0.22. Net revenue for the quarter ended Sept. 30 was $437.6 million, up from $384.3 million. Analysts polled by FactSet expected $423.5 million. ...
Medical aesthetic device maker Venus Concept's Q3 revenue misses
Medical aesthetic device maker Venus Concept's Q3 revenue misses
Nov 13, 2025
Overview * Venus Concept Q3 2025 revenue down 8% yr/yr, missing analyst expectations * Net loss widened to $22.5 mln in Q3, compared to $9.3 mln last year * Company completed debt-to-equity exchange, reducing debt by 24% Outlook * Company is not providing financial guidance for fiscal year 2025 * Company targets sequential growth in Q4 with Venus NOVA launch...
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
Nov 13, 2025
Overview * GoHealth Q3 2025 revenue declines 71% yr/yr, missing analyst expectations * Adjusted EBITDA for Q3 misses estimates, reflecting strategic pullback in Medicare Advantage * Company focuses on retention and quality amid changing Medicare market dynamics Outlook * Company secured superpriority term loan facility to enable strategic flexibility Result Drivers * MEDICARE ADVANTAGE PULLBACK - Co reduced Medicare Advantage...
Aura Biosciences Q3 net loss widens as R&D costs rise
Aura Biosciences Q3 net loss widens as R&D costs rise
Nov 13, 2025
Overview * Aura Biosciences ( AURA ) reports Q3 net loss of $26.1 mln, up from $21.0 mln last year * R&D expenses rise to $22.2 mln due to ongoing clinical trials Outlook * Aura expects Phase 3 CoMpass trial enrollment completion in 2026 * Topline data for CoMpass trial expected in Q4 2027 * Phase 1b/2 trial data for...
Copyright 2023-2025 - www.financetom.com All Rights Reserved